Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors
Natchaya Vanwong, Nattawat Ngamsamut, Nopphadol Nuntamool, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 17

Showing 17 citing articles:

Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications
Mohitosh Biswas, Natchaya Vanwong, Chonlaphat Sukasem
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
Predictive Role of Serotonin Receptor (5HTR2A) and Dopamine Receptor (DRD2) gene polymorphisms in risperidone-induced weight gain and hyperprolactinemia in patients with schizophrenia
Alladi Charanraj Goud, Ravi Philip Rajkumar, Deepak Gopal Shewade, et al.
European Journal of Clinical Pharmacology (2025)
Closed Access
Dietary nutrients that potentially mitigate autism spectrum disorder and dietary recommendations for children and pregnant women
Wentian Li, Qingmin Kong, Peijun Tian, et al.
Food Frontiers (2024) Vol. 5, Iss. 3, pp. 920-946
Open Access | Times Cited: 2
TAAR1 and 5-HT1B receptor agonists attenuate autism-like irritability and aggression in rats prenatally exposed to valproic acid
Lien Wang, Erin Clark, Lynsey Hanratty, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 245, pp. 173862-173862
Closed Access | Times Cited: 2
A Machine Learning Model to Predict Risperidone Active Moiety Concentration Based on Initial Therapeutic Drug Monitoring
Wei Guo, Ze Yu, Ya Gao, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 17
Body Composition and Anthropometric Measurements in Children and Adolescents with Autism Spectrum Disorder: A Case–Control Study in Lebanon
Melissa Rouphael, Yonna Sacre, Tania Bitar, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 847-847
Open Access | Times Cited: 1
Pharmacogenomics in clinical practice to prevent risperidone-induced hyperprolactinemia in autism spectrum disorder
Mohitosh Biswas, Natchaya Vanwong, Chonlaphat Sukasem
Pharmacogenomics (2022) Vol. 23, Iss. 8, pp. 493-503
Open Access | Times Cited: 7
Effect of risperidone on serum IL-6 levels in individuals with schizophrenia: a systematic review and meta-analysis
Miguel Ángel Ramos-Méndez, Carlos Alfonso Tovilla‐Zárate, Isela Esther Juárez‐Rojop, et al.
International Journal of Psychiatry in Clinical Practice (2022) Vol. 27, Iss. 2, pp. 171-178
Closed Access | Times Cited: 4
Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments
Marta Hernández, Natàlia Cullell, Marc Cendrós, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 244-244
Open Access
Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents
Rebecca A. Hermans, Ravish N. Gangapersad, Sanne Kloosterboer, et al.
European Neuropsychopharmacology (2024) Vol. 85, pp. 5-7
Closed Access
Exploring the relationships between extreme Body mass index and pain, somatic health, and psychiatric disorders in adolescents: a multinational analysis of general population data
Abdennour El Mzadi, Btissame Zouini, Kourosh Bador, et al.
Research Square (Research Square) (2024)
Open Access
Metabolic Side Effects of Risperidone in Pediatric Patients with Neurological Disorders: A Prospective Cohort Study
Jawza F. Alsabhan, Nouf Backer Al Backer, Fatimah M. Hassan, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5565-5565
Open Access
Trackers for Adverse Events in Child Mental Health: descriptive analysis using the global trigger tool
Sandna Larissa Freitas dos Santos, Ana Paula Soares Gondim
Brazilian Journal of Pharmaceutical Sciences (2023) Vol. 59
Open Access | Times Cited: 1
External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data
Eleni Karatza, Samit Ganguly, Chi D. Hornik, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 2
Deciphering Risperidone-Induced Lipogenesis by Network Pharmacology and Molecular Validation
Yun Fu, Ke Yang, Yepei Huang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 2
Fatores associados ao excesso de peso em crianças e adolescentes com Transtorno do Espectro Autista (TEA): uma revisão integrativa
Ana Vitória Brasil Pereira Furtado, Nívea Almeida Arcaro Topázio, Carolina Santos Mello
Research Society and Development (2022) Vol. 11, Iss. 11, pp. e345111133622-e345111133622
Open Access | Times Cited: 1
Applying Pharmacogenomics in Drug Therapy of Neurologic and Psychiatric Disorders
Y. W. Francis Lam
Elsevier eBooks (2021), pp. 277-301
Closed Access
Page 1

Scroll to top